Recent Updates
Recently added Catalysts
RLAY Positive Sentiment Score: 60/100

Relay Therapeutics to Announce First Quarter 2025 Financial Results and Corporate Highlights on May 5, 2025

Monday, April 28, 2025 1 min read
Key Takeaway: Relay Therapeutics is scheduled to announce its financial results for the first quarter of 2025 on May 5, 2025, after U.S. market close. The company is recognized for integrating advanced computational and experimental technologies in its drug discovery processes. This announcement reflects the company's continued operational developments in the biopharma space.

Market Sentiment Analysis

POSITIVE FACTORS

  • Announcement of financial results indicates ongoing corporate activity.
  • Relay Therapeutics is positioned for potential growth with innovative drug discovery technologies.

Full Press Release Details

CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will report first quarter 2025 financial results and corporate highlights after the U.S. financial markets close on Monday, May 5, 2025.
About Relay Therapeutics

Frequently Asked Questions

When will Relay Therapeutics report Q1 2025 financial results?

Relay Therapeutics will report Q1 2025 financial results on May 5, 2025.

What stock exchange is Relay Therapeutics listed on?

Relay Therapeutics is listed on the Nasdaq stock exchange under the ticker RLAY.

What technologies does Relay Therapeutics use in drug discovery?

Relay Therapeutics combines computational and experimental technologies for drug discovery.

Where is Relay Therapeutics located?

Relay Therapeutics is based in Cambridge, Massachusetts.

Tags: RLAY Viatris Investor Conferences Healthcare Relay Therapeutics financial results Q1 2025 precision medicine drug discovery
Last updated: Apr 28, 2025